论文部分内容阅读
乙丙脯氨酸[Enalapril,N-(1-乙氧羰基-3-苯丙基)-L-丙氨酰-L-脯氨酸——编者]是一种新的血管紧张素转换酶抑制剂,新近用于治疗高血压及充血性心力衰竭。有作者认为,本药加用于已进行利尿剂治疗的高血压时,首次量为10mg。因作者近来的经验提示这一剂量在某些患者来说是危险的,因此认为应作进一步探讨。作者报告1例47岁女性患者,用苄氟噻嗪(ben-drofluazide)每天5mg 作单一药物治疗4周后,分别接受安慰剂或 enalapril 10mg 与20mg 单剂口服至
Eproline [Enalapril, N- (1-ethoxycarbonyl-3-phenylpropyl) -L-alanyl-L-proline-Editor] is a novel angiotensin- Recently used to treat high blood pressure and congestive heart failure. Some authors believe that the drug plus diuretics have been used for the treatment of hypertension, the first amount of 10mg. As the author’s recent experience suggests that this dose is dangerous in some patients, it is believed that further discussion should be given. The authors report a 47-year-old female with ben-drofluazide 5 mg daily as a monotherapy for 4 weeks and placebo or enalapril 10 mg and 20 mg single-dose orally, respectively